Cytotoxicity of novel trifluoromethylquinoline derivatives on human leukemia cells

Citation
Jl. Kgokong et Jm. Wachira, Cytotoxicity of novel trifluoromethylquinoline derivatives on human leukemia cells, EUR J PH SC, 12(4), 2001, pp. 369-376
Citations number
25
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
ISSN journal
09280987 → ACNP
Volume
12
Issue
4
Year of publication
2001
Pages
369 - 376
Database
ISI
SICI code
0928-0987(200102)12:4<369:CONTDO>2.0.ZU;2-D
Abstract
This report is a comparative study of the in vitro cell-growth inhibitory a ctivity of six new trifluoromethylquinoline derivatives on human promyelocy tic leukemic cells and the evaluation of their DNA binding characteristics. 2,8-Bis(trifluoromethyl)quinoline-4-(N-4-ethyl-5-nitroimidazolo)methylene ketone shows the highest cell-growth inhibitory activity with IC50 of 10+/- 2.5 muM, causes extensive changes in the morphology of the HL-60 cells and appears to induce apoptosis. The other compounds are only moderately growth -inhibitory, while 8-trifluoromethylquinoline-4-(N-4-ethyl-5-nitroimidazolo )methylene ketone is actually stimulatory to cell growth. Except for the la tter, the cell growth inhibitory activity of these compounds appears to be due their ability to bind to and intercalate DNA. (C) 2001 Elsevier Science B.V. All rights reserved.